|
Development of New Approach Methodologies to Reduce Animal Use in Toxicity Testing -SBIR/STTR Town Hall Meeting
|
Meeting/ Workshop
|
FDA
|
NIEHS
|
This webinar-based town hall meeting was presented to facilitate improved communication between New Approach Methodologies (NAMs) method developers, including small business (SBIR/STTR) applicants, developing assays to reduce animal use in toxicity testing, and end-users and regulatory agency staff, providing an opportunity for the assay developers to hear from Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM), agency and industry stakeholders on the desired characteristics and requirements for NAM to meet testing requirements.
|
|
Development Of New Approaches To Vaccines Against Neurotropic Flaviviruses
|
Research Initiative
|
FDA
|
OD/OIR, NIAID
|
Development Of New Approaches To Vaccines Against Neurotropic Flaviviruses
|
|
Development testing of nucleic acid-based vaccine for HIV other indications
|
Research Initiative
|
FDA
|
NCI
|
Development testing of nucleic acid-based vaccine for HIV other indications
|
|
Diabetes Mellitus Interagency Coordinating Committee (DMICC)
|
Committee, Work group, Advisory group, or Task Force
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, OASH
|
NIDDK
|
The DMICC, chaired by NIDDK, facilitates cooperation, communication, and collaboration on diabetes among the participating government entities. DMICC meetings, held several times a year, help members identify emerging issues and opportunities and develop ways in which different government components can work together and build upon each other's expertise and resources. This approach helps ensure that federal diabetes activities are coordinated and not duplicated, as well as stimulates collaborations where appropriate.
|
|
Diabetes Prevention Program Outcomes Study (DPP/DPPOS)
|
Research Initiative
|
CDC
|
NIDDK, NCI, NHLBI, NIA
|
The Diabetes Prevention Program (DPP) showed that lifestyle change or the drug metformin delay the development of type 2 diabetes. The Diabetes Prevention Program Outcomes Study is studying the long-term effect of diet and exercise and the diabetes medication, metformin, on the delay of type 2 diabetes in participants of the DPP.
|
|
Diabetic Eye Disease Information Dissemination
|
Public Education Campaign
|
CDC
|
NEI
|
The Centers for Disease Control and Prevention (CDC's) National Diabetes Education Program is part of the National Eye Health Education Program Partnership. The National Eye Institute (NEI) continues to collaborate with CDC and other stakeholders to share information about diabetic eye disease with various communities.
|
|
Diagnosis, Treatment, and Medical Service Utilization in Medicare and Medicaid Population
|
Research Initiative
|
CMS
|
CC
|
Centers for Medicare and Medicaid Services (CMS) and the National Institutes of Health (NIH) Clinical Center (CC) Rehabilitation Medicine (RMD) agreed to collaborate in data-sharing for research, the results of which may be helpful to improve medical-service quality, utilization, and effectiveness for Medicare and Medicaid beneficiaries. CMS will provide electronic data to the NIH Clinical Center, which will perform analyses that are agreed to by both parties.
|
|
Diagnostics and Disease Management Tools for Use in Underserved Populations: An NHLBI Research & Implementation Workshop
|
Meeting/ Workshop
|
AHRQ, CMS, CDC, FDA, OASH, HRSA, IHS
|
NHLBI, NCATS, NIMHD, NIBIB
|
On April 14-15, 2021, the NHLBI convened a virtual workshop aimed at using technology to improve heart, lung, blood, and sleep health in historically underserved, low-resource, and remote communities. The goal was to identify more accessible and feasible technological solutions for disease diagnosis and management in these groups, highlight the ones that could have the greatest impact, and determine the ones best suited for further research. During the two-day event, approximately 1,800 participants came together to discuss sustainable and affordable technology solutions, effective community-based strategies, and innovative models for disease management and diagnosis in underserved populations. Participants included academic researchers, implementation scientists, technology and medical device experts, and community and federal health leaders.
|
|
Diet Induced Hypomethylation in Preneoplastic Liver
|
Research Initiative
|
FDA
|
NCI
|
The Food and Drug Administration (FDA)'s the National Center for Toxicological Research, and the National Cancer Institute (NCI)'s Division of Cancer Prevention, Nutritional Sciences Research Group are collaborating on an Interagency Agreement in which NCI will provide funds to examine the role of epigenetic mechanisms as factors that determine susceptibility to the development of hepatocellular carcinoma and to examine epigenetic alterations which may be used as markers of susceptibility to disease development, and whether correction of those epigenetic abnormalities during hepatocarcinogenesis may be a crucial decisive factor in cancer prevention strategies.
|
|
Dietary Supplement Label Database (DSLD)
|
Resource Development
|
FDA, CDC
|
OD/DPCPSI/ODS, NLM, OD/DPCPSI/ODSS, NCCIH, NCI
|
The National Institutes of Health's, Office of Dietary Supplement Dietary Supplement Label Database (DSLD) is a non-regulatory catalog of all information printed on labels of dietary supplement products sold in the United States. Label records in the DSLD are sourced from products reported in national population-based surveys, and through voluntary submissions by dietary supplement manufacturers and marketers. Information in the DSLD can be used by healthcare providers to determine the contents of the products their patients are taking, consumers can learn more about the ingredients listed on the Supplement Facts label by linking to nutrient fact sheets, and research scientists may use the DSLD in studies to derive nutrient intakes from supplements.
|